Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Ebola virus diversity assessed by sequencing

The report will provide an overview of Ebola virus diversity as assessed by sequencing necessary to optimize the diagnostic, treatment and vaccine approaches.

Whole infectious profiles

The report will provide an overview of the diversity of infectious profiles from available samples.

Ethical regulations, security and safety set up for diagnostic and follow-up of patients of the phase 1 (without treatment)

Ethical regulations set up to work with the present project for diagnostic and treatment

Creation of the specific website of the project

Creation of the specific website of the project.

Publicaciones

Metagenomic analyses and genomic fingerprint of co-infections of the EBOLA viral disease

Autores: W. Valdivia-, D. Sheoran, G. Dubois, S. Tigrett, F. Veas
Publicado en: 2015
Editor: Tofo conference on Filovirus, Ebola and Other Filoviruses

Development of a specific polyclonal immunoglobulin against Ebola

Autores: C. Herbreteau & IF Ebola
Publicado en: 2015
Editor: First World Congress on Targeting Ebola

Lessons Learned from the Development of an Ebola Immunotherapy

Autores: R Metrop, JF Saluzzo, F Veas, C. Herbreteau
Publicado en: 2017
Editor: IV International Conference on Mitigation Strategies for Emerging Infectious diseases

Specific polyclonal F(ab’)2immunoglobulin fragments; in vitro characterization and in vivo effectiveness in post-exposure treatment against Zaire Ebola virus in mice

Autores: M. Denizot, T. Racine, D. Pannetier, A. Pasquier, H. Raoul, JF Saluzzo, G. Kobinger, F. Veas, C. Herbreteau
Publicado en: 2017
Editor: The II International Conference CBRNE - Research & Innovation

Atypical immune response of EVD Long-term survivors

Autores: Y. Eskira A Sobarzo, F Veas L Lobel
Publicado en: 2017
Editor: VIII International Conference on Emerging Zoonoses and transboundary Infectious Diseases

The preparedness IF-EBOLA toolbox for rapid and efficient mitigation of upcoming outbreaks. A platform model for emerging diseases

Autores: F.Veas
Publicado en: 2016
Editor: International Conference on Mitigation Strategies for Emerging Infectious diseases

Efficiency of innovative preparedness IF-EBOLA technologies: Ultrasensitive diagnostics, horse anti-Ebola virus polyclonal Fabs & metagenomic analyses of Ebola variants and co-infections

Autores: F.Veas
Publicado en: 2017
Editor: IV International Conference on Mitigation Strategies for Emerging Infectious diseases

Ebola virus Genomic and Metagenomic signature Analyses of the 2014-15 West African Outbreak

Autores: W. Valdivia, D. Sheoran, & F. Veas
Publicado en: Edición 7th Filovirus Conference, 2015
Editor: 7th Filovirus Conference

Multi-technological platforms to solve unmet needs for rapid and efficient management of emerging diseases

Autores: F.Veas
Publicado en: 2015
Editor: XIX International Congress for Tropical Diseases

A Universal virus capture method leading to a rapid and ultrasensitive detection of pathogens for early & late post-exposure countermeasures

Autores: S Tigrett, L Lobel, F Veas
Publicado en: 2017
Editor: VIII International Conference on Emerging Zoonoses and transboundary Infectious diseases

RIGEL as a Powerful Computational Architecture for Genomic & Metagenomic Signature Discrimination: Analysis of the 2014-15 West African EBOLA Outbreak”

Autores: W. Valdivia, D. Sheoran & F. Veas
Publicado en: Edición Gordon Research Conferences, on Biodefense and Bioterrorism meeting, 2015, Página(s) March 8-13, 2015
Editor: Gordon Research Conference

Resveratrol-Linoleate protects from exacerbated endothelial permeability via a drastic inhibition of the MMP-9 activity

Autores: A Shamseddin, C Crauste, E Durand, P Villeneuve, G Dubois, T Pavlickova, Th Durand, J. Vercauteren, and F Veas
Publicado en: 2018
Editor: BioScience Reports 2018

Resveratrol formulated with a natural deep eutectic solvent inhibits active matrix metalloprotease-9 in hormetic conditions

Autores: Aly Shamseddin, Céline Crauste, Erwann Durand, Pierre Villeneuve, Gregor Dubois, Thierry Durand, Joseph Vercauteren, Francisco Veas
Publicado en: European Journal of Lipid Science and Technology, Edición 119/11, 2017, Página(s) 1700171, ISSN 1438-7697
Editor: Wiley - V C H Verlag GmbbH & Co.
DOI: 10.1002/ejlt.201700171

Buscando datos de OpenAIRE...

Resultado final

Publicaciones

Compartir esta página

Descargar